Anti-Human IL17 Therapeutic Antibody (Afasevikumab)
Recombinant monoclonal antibody to IL17. Afasevikumab is a human monoclonal antibody that can be potentially used in the treatment of Multiple sclerosis (MS).
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-474CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | IL17A and IL17F |
| Species Reactivity | Human |
| Type | IgG1, κ |
| Applications | Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition |
| Storage | Store at -20°C for long-term storage. Avoid freeze/thaw cycles. |